SkinBioTherapeutics targets European roll out in next six months
29 Mar 2022 //
PROACTIVEINVESTOR
SkinBioTherapeutics CEO says company still at start of the journey
29 Mar 2022 //
PROACTIVE INVESTORS
SkinBioTherapeutics Shares Drop 30% After Widened 1H Pretax Loss
29 Mar 2022 //
MARKET WATCH
SkinBioTherapeutics as part of the ‘Great Ideas’ column in this week’s issue
17 Jun 2021 //
PRESS RELEASE
Positive data for AxisBiotix-Ps™ food supplement consumer study unveiled
27 May 2021 //
PRESS RELEASE
New oral health research programme initiated with the University of Manchester
27 Apr 2021 //
PRESS RELEASE
New research agreement initiated with the University of Manchester
08 Apr 2021 //
PRESS RELEASE
Expanded enrolment for AxisBiotix-PsTM food supplement consumer study
01 Feb 2021 //
PRESS RELEASE
CEO Stuart Ashman discusses enrolment for the AxisBiotix food supplement study
24 Jan 2021 //
PRESS RELEASE